Previous 10 | Next 10 |
Thermo Fisher Scientific is an under-the-radar healthcare company that prints money. What does Thermo Fisher do? Science! Some examples – manufacturing of lab equipment, diagnostic tests, and vaccines. They have a fast-growing clinical research business as well. Thermo Fish...
Azenta's core markets are expected to grow 15%-20% per annum for the next five years. When looking at visibility of earnings approximately 75% of AZTA’s revenue is recurring with a customer base intent on storing for up to 25 years. This should lead to the conclusion this i...
Beckman Coulter Partners with Mass General and BARDA to Identify Severe Pediatric Infections in Emergency Departments PR Newswire BREA, Calif. , July 25, 2022 /PRNewswire/ -- Beckman Coulter, global leader in advanced diagnostics, today announced that it ...
This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management. From 1/2/2016 to date, investing in all 50 stocks, equally weighted, would have produced a total return of 84.7%, a...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list is a monthly...
In this article, I start by explaining why I made the decision to add low-yielding Danaher to my dividend growth portfolio as it's all based on the expected total return. We then look into the company's 2Q22 earnings, which were better than I expected as the company continues to execu...
“Defensive” and “high quality” is what RBC Capital Markets called Danaher Corporation (NYSE:DHR) stock. In a note on Wednesday, RBC said that Danaher’s leverage of only 1.7 times makes the stock attractive. The analysts expressed the satisfaction t...
Diagnostics companies and others that support the life sciences industry are higher in Thursday afternoon trading following Danaher's ( NYSE: DHR ) Q2 2022 top and bottom lines beats . Danaher ( DHR ) is up 8% . Thermo Fisher Scientific ( NYSE: TMO ) an...
Earnings season has begun to heat up, with quarterly results playing a significant role in Thursday's midday trading. The release of financial figures spurred gains in Philip Morris ( NYSE: PM ), Nokia ( NOK ) and Danaher ( DHR ). On the other side of the spectrum, Ameri...
Danaher Corporation (DHR) Q2 2022 Earnings Conference Call July 21, 2022 8:00 AM ET Company Participants John Bedford – Vice President-Investor Relations Rainer Blair – President and Chief Executive Officer Matt McGrew – Executive Vice Presid...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...